title: Methylseleninic acid antagonizes the cytotoxic effect of bortezomib in mantle cell lymphoma cell lines through modulation of Bcl-2 family proteins.
authors.forename: Shireen
authors.initials: S
authors.lastname: Kassam
authors.forename: Simone
authors.initials: S
authors.lastname: Juliger
authors.forename: Li
authors.initials: L
authors.lastname: Jia
authors.forename: Simon P
authors.initials: SP
authors.lastname: Joel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001897:Boronic Acids / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000069286:Bortezomib; D045744:Cell Line, Tumor; D004347:Drug Interactions; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D008297:Male; D016566:Organoselenium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D011719:Pyrazines / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000494:pharmacology
chemical_list: D001897:Boronic Acids; D016566:Organoselenium Compounds; D019253:Proto-Oncogene Proteins c-bcl-2; D011719:Pyrazines; D000069286:Bortezomib; C008493:methylselenic acid